Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09).
about
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine.Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines.Obesity and Cancer Mechanisms: Cancer Metabolism.
P2860
Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Multidrug and toxin extrusion ...... eiving metformin (SAKK 08/09).
@en
Multidrug and toxin extrusion ...... ate cancer receiving metformin
@nl
type
label
Multidrug and toxin extrusion ...... eiving metformin (SAKK 08/09).
@en
Multidrug and toxin extrusion ...... ate cancer receiving metformin
@nl
prefLabel
Multidrug and toxin extrusion ...... eiving metformin (SAKK 08/09).
@en
Multidrug and toxin extrusion ...... ate cancer receiving metformin
@nl
P2093
P2860
P50
P356
P1476
Multidrug and toxin extrusion ...... ceiving metformin (SAKK 08/09)
@en
P2093
R Cathomas
R H N van Schaik
R Winterhalder
P2860
P2888
P304
P356
10.1038/PCAN.2015.8
P577
2015-03-10T00:00:00Z